Reflections on the Innovative Medicines Initiative

被引：0
|
作者：
Michel Goldman
机构：
[1] Michel Goldman is Executive Director of the Innovative Medicines Initiative,
[2] B-1060 Brussels,undefined
[3] Belgium.,undefined
来源：
Nature Reviews Drug Discovery | 2011年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public–private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
引用
收藏
页码：321 / 322
页数：1
相关论文
共 50 条
  • [21] Innovative Medicines Initiative plays the long game on research funding
    Meulien, Pierre
    NATURE MICROBIOLOGY, 2021, 6 (02) : 137 - 137
  • [22] Innovative Medicines Initiative plays the long game on research funding
    Pierre Meulien
    Nature Microbiology, 2021, 6 : 137 - 137
  • [23] Innovative medicines initiative: From semantic data integration to risk assessment
    Digles, Daniela
    Goldmann, Daria
    Zdrazil, Barbara
    Ecker, Gerhard
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [24] The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
    Halban, P. A.
    DIABETOLOGIA, 2007, 50 (09) : 1791 - 1794
  • [25] The Rational Use of Animals in Drug Development: Contribution of the Innovative Medicines Initiative
    Gunn, Magda
    Vaudano, Elisabetta
    Goldman, Michel
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2012, 40 (06): : 307 - 312
  • [26] The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
    P. A. Halban
    Diabetologia, 2007, 50 : 1791 - 1794
  • [27] In silico prediction of in vivo toxicities (eTox)-The Innovative Medicines Initiative Approach
    Steger-Hartmann, Thomas
    Pognan, Francois
    Sanz, Ferran
    Acedo Diaz, Carlos
    TOXICOLOGY LETTERS, 2009, 189 : S258 - S258
  • [28] The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients
    Hunter, A. Jackie
    DRUG DISCOVERY TODAY, 2008, 13 (9-10) : 371 - 373
  • [29] The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks
    O'Rourke, Diana
    Coll-Padros, Nina
    Bradshaw, Angela
    Killin, Lewis
    Pradier, Laurent
    Georges, Jean
    Dawoud, Dalia M.
    Steukers, Lennert
    Diaz, Carlos
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [30] Panel discussion: The Innovative Medicines Initiative (IMI) - high hopes and first experiences
    Steger-Hartmann, Thomas
    Pfannkuch, Friedlieb
    TOXICOLOGY LETTERS, 2009, 189 : S14 - S14
12345